Therapeutic effectiveness against mopc—315 plasmacytoma of low or high doses of the synthetic thymic hormone THF—γ2 in combination with an “immunomodulating” or a “non—immunomodulating” drug
R. Ophir, M. Pecht, Y. Burstein, H. Harshemesh, S. Ben-Efraim, N. TraininVolume:
48
Year:
1991
Language:
english
Pages:
5
DOI:
10.1002/ijc.2910480118
File:
PDF, 453 KB
english, 1991